To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes.

Bill 110 hr 6432, also known as the Animal Drug User Fee Amendments of 2020, aims to amend the Federal Food, Drug, and Cosmetic Act in order to revise and extend the animal drug user fee program. This bill also seeks to establish a program of fees related to generic new animal drugs. Additionally, it includes provisions to make technical corrections to the Food and Drug Administration Amendments Act of 2007.

The main goal of this legislation is to improve the regulation and oversight of animal drugs in the United States. By implementing user fees for animal drug manufacturers, the bill aims to provide the Food and Drug Administration (FDA) with additional resources to review and approve new animal drugs in a timely manner. This will help ensure the safety and effectiveness of these products for animals.

Furthermore, the bill includes provisions to streamline the approval process for generic new animal drugs, making it easier for manufacturers to bring these products to market. This will increase competition in the animal drug market, potentially leading to lower prices for consumers. Overall, Bill 110 hr 6432 is designed to enhance the regulation of animal drugs in the US, improve access to safe and effective medications for animals, and promote innovation in the animal drug industry.